We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
-12.87%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$266M
AUM Growth
-$36M
Cap. Flow
+$4.9M
Cap. Flow %
1.84%
Top 10 Hldgs %
54.75%
Holding
84
New
18
Increased
15
Reduced
8
Closed
22

Top Buys

Rank Stock Value
1
OGN icon
Organon & Co
OGN
+$20.1M
2
COR icon
Cencora
COR
+$15.3M
3
BCYC
Bicycle Therapeutics
BCYC
+$13.4M
4
HCA icon
HCA Healthcare
HCA
+$13.3M
5
MDT icon
Medtronic
MDT
+$8.11M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$16M
2
SNY icon
Sanofi
SNY
+$15.4M
3
LH icon
Labcorp
LH
+$13M
4
MCK icon
McKesson
MCK
+$10.6M
5
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$9.1M

Sector Composition

Rank Sector Weight
1 Healthcare 83.9%
2 Financials 8.53%
3 Consumer Staples 1.75%
4 Industrials 0.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XENE icon
51
Xenon Pharmaceuticals
XENE
$6.02B
$498K 0.19%
16,368
-89,388
-85% -$2.7M
BGMS
52
Bio Green Med Solution Inc
BGMS
$4.86M
$491K 0.18%
126
+9
+8% +$54.4K
ARDX icon
53
Ardelyx
ARDX
$1.23B
$408K 0.15%
+692,357
New +$510K
XFOR icon
54
X4 Pharmaceuticals
XFOR
$386M
$267K 0.1%
9,230
– –
NYXH
55
Nyxoah
NYXH
$146M
$148K 0.06%
16,110
– –
VINC
56
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$135K 0.05%
5,102
– –
CMAX
57
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$112K 0.04%
1,025
– –
BHC icon
58
Bausch Health
BHC
$2.62B
$56K 0.02%
+6,700
New +$93.7K
HUMAW icon
59
Humacyte Inc Warrant
HUMAW
$1.27M
$45K 0.02%
49,998
– –
NGNE icon
60
Neurogene
NGNE
$656M
$39K 0.01%
1,916
– –
RCOR.WS
61
DELISTED
Renovacor, Inc. Warrants, entitling the holder thereof to purchase one-half (1/2) of a share of common stock at a price of $11. 50 per whole share
RCOR.WS
$34K 0.01%
400,000
– –
CMAXW
62
DELISTED
CareMax, Inc. Warrant
CMAXW
$9K ﹤0.01%
12,808
– –
AVAH icon
63
Aveanna Healthcare
AVAH
$2.09B
– –
-131,812
Closed -$449K
CRIS icon
64
Curis
CRIS
$10M
– –
-4,789
Closed -$4.56M
LKFT
65
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.75B
– –
-146,696
Closed -$9.1M
IONS icon
66
Ionis Pharmaceuticals
IONS
$9.06B
– –
-175,568
Closed -$6.5M
KOD icon
67
CALL
Kodiak Sciences
KOD
$2.49B
– –
-30,600
Closed -$236K
KZR
68
DELISTED
Kezar Life Sciences
KZR
– –
-917
Closed -$152K
LH icon
69
Labcorp
LH
$24.9B
– –
-57,418
Closed -$13M
MCK icon
70
McKesson
MCK
$96.8B
– –
-34,501
Closed -$10.6M
MEDP icon
71
Medpace
MEDP
$16B
– –
-28,400
Closed -$4.65M
MIRM icon
72
Mirum Pharmaceuticals
MIRM
$6.38B
– –
-161,285
Closed -$3.55M
MRK icon
73
Merck
MRK
$316B
– –
-195,160
Closed -$16M
NKTR icon
74
PUT
Nektar Therapeutics
NKTR
$2.38B
– –
-46,247
Closed -$3.74M
SNY icon
75
Sanofi
SNY
$103B
– –
-300,000
Closed -$15.4M
1 2
3
4

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $698M AUM 17.36% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return

Sio Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Sio Capital Management held 84 positions worth $266M, down 12% from $302M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Sio Capital Management's Q2 2022 filing shows 18 new, 15 increased, 8 reduced and 22 closed positions. Its largest new stake was Organon & Co: 574,855 shares worth $19.4M. The largest sale was Merck, an estimated $16M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 73% a quarter earlier, followed by Financials and Consumer Staples.

  • Sio Capital Management's largest Q2 2022 buy was Organon & Co: 574,855 shares worth $19.4M.
  • Sio Capital Management added most to Cencora in Q2 2022, an estimated $15.3M increase.
  • Sio Capital Management's biggest Q2 2022 reduction was Cigna, cutting an estimated $3.81M.
  • Sio Capital Management fully exited Merck in Q2 2022, selling an estimated $16M.
  • Sio Capital Management's ten largest holdings make up 55% of its $266M portfolio in Q2 2022.
  • Sio Capital Management opened 18 new positions and closed 22 in Q2 2022.
  • Sio Capital Management's portfolio value fell 12% quarter-over-quarter to $266M.

Based on Sio Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.